Progress in the Development of Eukaryotic Elongation Factor 2 Kinase (eEF2K) Natural Product and Synthetic Small Molecule Inhibitors for Cancer Chemotherapy

Eukaryotic elongation factor 2 kinase (eEF2K or Ca(2+)/calmodulin-dependent protein kinase, CAMKIII) is a new member of an atypical α-kinase family different from conventional protein kinases that is now considered as a potential target for the treatment of cancer. This protein regulates the phospho...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Bin, Zou, Jiamei, Zhang, Qiting, Wang, Ze, Wang, Ning, He, Shan, Zhao, Yufen, Naman, C. Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957638/
https://www.ncbi.nlm.nih.gov/pubmed/33673713
http://dx.doi.org/10.3390/ijms22052408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957638/
https://www.ncbi.nlm.nih.gov/pubmed/33673713
http://dx.doi.org/10.3390/ijms22052408

Ejemplares similares